References
- VercelliniP, ViganòP, SomiglianaE, etal. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275. doi:10.1038/nrendo.2013.25524366116
- ShafrirAL, FarlandLV, ShahDK, etal. Risk for and consequences of endometriosis: acritical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1–15. doi:10.1016/j.bpobgyn.2018.06.00130017581
- GiudiceLC. Clinical practice. Endometriosis. NEngl JMed. 2010;362(25):2389–2398. doi:10.1056/NEJMcp1000274
- MehedintuC, PlotogeaMN, IonescuS, AntonoviciM. Endometriosis still a challenge. JMed Life. 2014;7(3):349–357.25408753
- HalpernG, SchorE, KopelmanA. Nutritional aspects related to endometriosis. Rev Assoc Med Bras (1992). 2015;61(6):519–523. doi:10.1590/1806-9282.61.06.51926841161
- MeresmanGF, GötteM, LaschkeMW. Plants as source of new therapies for endometriosis: areview of preclinical and clinical studies. Hum Reprod Update. 2021;27(2):367–392. doi:10.1093/humupd/dmaa03933124671
- ParkHS, LimJH, KimMY, etal. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy. JTransl Med. 2016;14(1):176. doi:10.1186/s12967-016-0922-927286657
- HuminieckiL, HorbańczukJ. The functional genomic studies of resveratrol in respect to its anti-cancer effects. Biotechnol Adv. 2018;36(6):1699–1708. doi:10.1016/j.biotechadv.2018.02.01129476886
- PrysyazhnaO, WolhuterK, SwitzerC, etal. Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase. Circulation. 2019;140(2):126–137. doi:10.1161/CIRCULATIONAHA.118.03739831116951
- Mendes da SilvaD, GrossLA, NetoEDPG, etal. The use of resveratrol as an adjuvant treatment of pain in endometriosis: arandomized clinical trial. JEndocr Soc. 2017;1(4):359–369. doi:10.1210/js.2017-0005329264492
- Kolahdouz MohammadiR, ArablouT. Resveratrol and endometriosis: invitro and animal studies and underlying mechanisms (Review). Biomed Pharmacother. 2017;91:220–228. doi:10.1016/j.biopha.2017.04.07828458160
- Kolahdouz-MohammadiR, ShidfarF, KhodaverdiS, etal. Resveratrol treatment reduces expression of MCP-1, IL-6, IL-8 and RANTES in endometriotic stromal cells. JCell Mol Med. 2021;25(2):1116–1127. doi:10.1111/jcmm.1617833325132
- Rudzitis-AuthJ, MengerMD, LaschkeMW. Resveratrol is apotent inhibitor of vascularization and cell proliferation in experimental endometriosis. Hum Reprod. 2013;28(5):1339–1347. doi:10.1093/humrep/det03123427233
- ErgenoğluAM, YenielAÖ, ErbaşO, etal. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats. Reprod Sci. 2013;20(10):1230–1236. doi:10.1177/193371911348301423536571
- Bayoglu TekinY, GuvenS, KirbasA, etal. Is resveratrol apotential substitute for leuprolide acetate in experimental endometriosis?Eur JObstet Gynecol Reprod Biol. 2015;184:1–6. doi:10.1016/j.ejogrb.2014.10.04125462211
- YavuzS, AydinN, CelikO, etal. Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation. JCancer Res Ther. 2014;10(2):324–329. doi:10.4103/0973-1482.13661925022386
- VillanuevaJA, SokalskaA, CressAB, etal. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells. JClin Endocrinol Metab. 2013;98(3):E455–E462. doi:10.1210/jc.2012-338723386644
- TaguchiA, KogaK, KawanaK, etal. Resveratrol enhances apoptosis in endometriotic stromal cells. Am JReprod Immunol. 2016;75(4):486–492. doi:10.1111/aji.1248926782781
- TaguchiA, Wada-HiraikeO, KawanaK, etal. Resveratrol suppresses inflammatory responses in endometrial stromal cells derived from endometriosis: apossible role of the sirtuin 1 pathway. JObstet Gynaecol Res. 2014;40(3):770–778. doi:10.1111/jog.1225224320086
- KhodarahmianM, AmidiF, MoiniA, etal. Arandomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women. JReprod Immunol. 2021;143:103248. doi:10.1016/j.jri.2020.10324833387724
- ChenS, LuoY, CuiL, etal. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1. Cell Cycle. 2020;19(14):1740–1753. doi:10.1080/15384101.2020.177780432635855
- WangD, LuoY, WangG, etal. Circular RNA expression profiles and bioinformatics analysis in ovarian endometriosis. Mol Genet Genomic Med. 2019;7(7):e00756. doi:10.1002/mgg3.75631144476
- FerreroH, CorachánA, AguilarA, etal. Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals adifferential transcriptomic profile associated with lower quality. Hum Reprod. 2019;34(7):1302–1312. doi:10.1093/humrep/dez05331211846
- Vallvé-JuanicoJ, SantamariaX, VoKC, etal. Macrophages display proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease. Fertil Steril. 2019;112(6):1118–1128. doi:10.1016/j.fertnstert.2019.08.06031843088
- WarrenLA, ShihA, RenteiraSM, etal. Analysis of menstrual effluent: diagnostic potential for endometriosis. Mol Med. 2018;24(1):1. doi:10.1186/s10020-018-0009-630134794
- MartinezFO, GordonS. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13. doi:10.12703/P6-1324669294
- IvashkivLB. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 2013;34(5):216–223. doi:10.1016/j.it.2012.11.00123218730
- MurrayPJ, AllenJ, BiswasS, etal. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi:10.1016/j.immuni.2014.06.00825035950
- SmithSR, LovejoyJC, GreenwayF, etal. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50(4):425–435. doi:10.1053/meta.2001.2169311288037
- TordjmanJ, DivouxA, PriftiE, etal. Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity. JHepatol. 2012;56(5):1152–1158. doi:10.1016/j.jhep.2011.12.01522245892
- GolanR, ShelefI, RudichA, etal. Abdominal superficial subcutaneous fat: aputative distinct protective fat subdepot in type 2 diabetes. Diabetes Care. 2012;35(3):640–647. doi:10.2337/dc11-158322344612
- NieMF, XieQ, WuY-H, etal. Serum and ectopic endometrium from women with endometriosis modulate macrophage M1/M2 polarization via the Smad2/Smad3 pathway. JImmunol Res. 2018;2018:6285813. doi:10.1155/2018/628581330276219
- LaganàAS, SalmeriFM, Ban FrangežH, etal. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinol. 2020;36(5):441–444. doi:10.1080/09513590.2019.168382131663401
- LiuY, ZhangW. Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget. 2017;8(29):46928–46936. doi:10.18632/oncotarget.1491628159926
- Lafay PilletMC, SchneiderA, BorgheseB, etal. Deep infiltrating endometriosis is associated with markedly lower body mass index: a476 case-control study. Hum Reprod. 2012;27(1):265–272. doi:10.1093/humrep/der34622025227
- CristanchoAG, LazarMA. Forming functional fat: agrowing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12(11):722–734. doi:10.1038/nrm319821952300
- LiZY, SongJ, ZhengS-L, etal. Adipocyte metrnl antagonizes insulin resistance through PPARγ signaling. Diabetes. 2015;64(12):4011–4022. doi:10.2337/db15-027426307585
- OdegaardJI, Ricardo-GonzalezRR, GoforthMH, etal. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007;447(7148):1116–1120. doi:10.1038/nature0589417515919
- HeringtonJL, GloreDR, LucasJA, etal. Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in achimeric mouse model. Fertil Steril. 2013;99(2):543–550. doi:10.1016/j.fertnstert.2012.10.00723103017
- Garaicoa-PazminoC, FretwurstT, SquarizeCH, etal. Characterization of macrophage polarization in periodontal disease. JClin Periodontol. 2019;46(8):830–839. doi:10.1111/jcpe.1315631152604
- SunH, LiD, YuanM, etal. Macrophages alternatively activated by endometriosis-exosomes contribute to the development of lesions in mice. Mol Hum Reprod. 2019;25(1):5–16. doi:10.1093/molehr/gay04930428082
- GemmatiD, ViglianoM, BuriniF, etal. Coagulation factor XIIIA (F13A1): novel perspectives in treatment and pharmacogenetics. Curr Pharm Des. 2016;22(11):1449–1459. doi:10.2174/138161282266615121012295426654441
- AnMY, EoH, SonH, etal. Anti‑inflammatory effects of leaf and branch extracts of honeyberry (Lonicera caerulea) on lipopolysaccharide‑stimulated RAW264.7 cells through ATF3 and Nrf2/HO‑1 activation. Mol Med Rep. 2020;22(6):5219–5230. doi:10.3892/mmr.2020.1163833174016
- DiamantopoulouZ, WhiteG, FadlullahMZH, etal. TIAM1 antagonizes TAZ/YAP both in the destruction complex in the cytoplasm and in the nucleus to inhibit invasion of intestinal epithelial cells. Cancer Cell. 2017;31(5):621–634.e6. doi:10.1016/j.ccell.2017.03.00728416184
- TangY, LiH, LiJ, etal. Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil-mediated complement activation. JHepatol. 2018;68(4):733–743. doi:10.1016/j.jhep.2017.11.01029154963
- RhodesNP, HuntJA, WilliamsDF. Macrophage subpopulation differentiation by stimulation with biomaterials. JBiomed Mater Res. 1997;37(4):481–488. doi:10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H9407296
- SuzukiHI, YamagataK, SugimotoK, etal. Modulation of microRNA processing by p53. Nature. 2009;460(7254):529–533. doi:10.1038/nature0819919626115
- TsudaT, TakefujiM, WettschureckN, etal. Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction. JExp Med. 2017;214(7):1877–1888. doi:10.1084/jem.2016192428550160
- ZhengyunC, Chunyan W, Cuicui L, et al. The Lipid-related Effects of Resveratrol on Human Ectopic Endometrial Stromal Cells and a Rat Model of Endometriosis. Research Square. doi:10.21203/rs.3.rs-110546/v1
- GuoL, TabrizchiR. Peroxisome proliferator-activated receptor gamma as adrug target in the pathogenesis of insulin resistance. Pharmacol Ther. 2006;111(1):145–173.16305809
- KennedyS, BergqvistA, ChapronC, etal. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20(10):2698–2704. doi:10.1093/humrep/dei13515980014
- BallardKD, SeamanHE, de VriesCS, etal. Can symptomatology help in the diagnosis of endometriosis? Findings from anational case-control study–part 1. Bjog. 2008;115(11):1382–1391. doi:10.1111/j.1471-0528.2008.01878.x18715240
- WallerKG, LindsayP, CurtisP, etal. The prevalence of endometriosis in women with infertile partners. Eur JObstet Gynecol Reprod Biol. 1993;48(2):135–139. doi:10.1016/0028-2243(93)90254-A8491333
- SeamanHE, BallardKD, WrightJT, etal. Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from anational case-control study–part 2. Bjog. 2008;115(11):1392–1396. doi:10.1111/j.1471-0528.2008.01879.x18715239
- DullAM, MogaMA, DimienescuOG, etal. Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways. Molecules. 2019;24(4):667. doi:10.3390/molecules24040667
- ChenFY, WangX, TangR-Y, etal. New therapeutic approaches for endometriosis besides hormonal therapy. Chin Med J(Engl). 2019;132(24):2984–2993. doi:10.1097/CM9.000000000000056931809322
- KhazaeiMR, RashidiZ, ChobsazF, etal. Inhibitory effect of resveratrol on the growth and angiogenesis of human endometrial tissue in an invitro three-dimensional model of endometriosis. Reprod Biol. 2020;20(4):484–490. doi:10.1016/j.repbio.2020.07.01232896495
- BódisK, RodenM. Energy metabolism of white adipose tissue and insulin resistance in humans. Eur JClin Invest. 2018;48(11):e13017. doi:10.1111/eci.1301730107041
- WagnerN, WagnerKD. PPARs and angiogenesis-implications in pathology. IntJMol Sci. 2020;21(16):5723. doi:10.3390/ijms21165723
- YoshinoO, OsugaY, HirotaY, etal. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am JReprod Immunol. 2004;52(5):306–311. doi:10.1111/j.1600-0897.2004.00231.x15550066